MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-29-2023
Chembio Diagnostics P/S Ratio 2011-2026 | CEMI
Annual P/S Ratio Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.254 | 0.579 | 4.35 | 1.97 | 3.02 | 4.25 | 3.24 | 1.94 | 1.29 | 1.11 | 1.64 | 1.53 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.35 | 0.254 | 2.1 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
1.37 | $ 19.75 | -20.22 % | $ 572 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
6.87 | $ 17.17 | 0.94 % | $ 181 M |  China |
 |
Agilent Technologies
A
|
6.64 | $ 118.47 | 0.66 % | $ 36 B | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 430.5 | 0.87 % | $ 12.4 B | USA |
 |
Myriad Genetics
MYGN
|
0.496 | $ 4.08 | -0.85 % | $ 378 M | USA |
 |
NeoGenomics
NEO
|
2.04 | $ 9.02 | 1.41 % | $ 1.16 B | USA |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
National Research Corporation
NRC
|
2.29 | $ 17.85 | -0.06 % | $ 400 M | USA |
 |
Natera
NTRA
|
6.47 | $ 214.99 | -0.05 % | $ 21.2 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.7 | $ 27.43 | 0.72 % | $ 26 B |  Niderland |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | USA |
 |
Personalis
PSNL
|
3 | $ 5.97 | -1.65 % | $ 354 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
Soleno Therapeutics
SLNO
|
10.9 | $ 52.92 | -0.04 % | $ 2.69 B | USA |
 |
CareDx, Inc
CDNA
|
2.61 | $ 21.58 | 3.06 % | $ 1.15 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
9.4 | $ 1.8 | 9.67 % | $ 2.39 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
Trinity Biotech plc
TRIB
|
3.15 | $ 0.62 | 3.64 % | $ 223 M |  Irlanda |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Twist Bioscience Corporation
TWST
|
4.15 | $ 58.34 | -2.0 % | $ 3.49 B | USA |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 187.92 | 3.41 % | $ 9.31 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 15.03 | 0.74 % | $ 454 M | USA |
 |
Guardant Health
GH
|
13.7 | $ 89.49 | -3.0 % | $ 11.2 B | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 123.87 | -0.21 % | $ 10.2 B | Irlanda |
 |
Illumina
ILMN
|
3.75 | $ 139.44 | -2.2 % | $ 22.2 B | USA |
 |
Senseonics Holdings
SENS
|
9.94 | $ 5.21 | -2.89 % | $ 217 M | USA |
 |
Interpace Biosciences
IDXG
|
0.19 | $ 2.04 | -3.33 % | $ 9.02 M | USA |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
1.35 | $ 2.17 | -1.84 % | $ 4.98 M | USA |
 |
Thermo Fisher Scientific
TMO
|
4.4 | $ 471.91 | -0.22 % | $ 178 B | USA |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 90.65 | 5.22 % | $ 6.12 B | USA |
 |
Waters Corporation
WAT
|
21.1 | $ 345.8 | -1.15 % | $ 20.6 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 258.68 | 0.68 % | $ 21.5 B | USA |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
1.14 | $ 9.22 | 0.44 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 189.94 | 0.43 % | $ 21.1 B | USA |